JP2014524733A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524733A5
JP2014524733A5 JP2013549652A JP2013549652A JP2014524733A5 JP 2014524733 A5 JP2014524733 A5 JP 2014524733A5 JP 2013549652 A JP2013549652 A JP 2013549652A JP 2013549652 A JP2013549652 A JP 2013549652A JP 2014524733 A5 JP2014524733 A5 JP 2014524733A5
Authority
JP
Japan
Prior art keywords
seq
represented
heavy chain
light chain
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013549652A
Other languages
English (en)
Japanese (ja)
Other versions
JP6001557B2 (ja
JP2014524733A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013549652A priority Critical patent/JP6001557B2/ja
Priority claimed from PCT/JP2012/061795 external-priority patent/WO2012148003A1/en
Publication of JP2014524733A publication Critical patent/JP2014524733A/ja
Publication of JP2014524733A5 publication Critical patent/JP2014524733A5/ja
Application granted granted Critical
Publication of JP6001557B2 publication Critical patent/JP6001557B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013549652A 2011-04-28 2012-04-27 抗ヒト受容体型プロテインチロシンホスファターゼσ抗体 Active JP6001557B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013549652A JP6001557B2 (ja) 2011-04-28 2012-04-27 抗ヒト受容体型プロテインチロシンホスファターゼσ抗体

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2011101752 2011-04-28
JP2011101752 2011-04-28
PCT/JP2012/061795 WO2012148003A1 (en) 2011-04-28 2012-04-27 ANTI-HUMAN RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE σ ANTIBODY
JP2013549652A JP6001557B2 (ja) 2011-04-28 2012-04-27 抗ヒト受容体型プロテインチロシンホスファターゼσ抗体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016170634A Division JP6412072B2 (ja) 2011-04-28 2016-09-01 抗ヒト受容体型プロテインチロシンホスファターゼσ抗体

Publications (3)

Publication Number Publication Date
JP2014524733A JP2014524733A (ja) 2014-09-25
JP2014524733A5 true JP2014524733A5 (enExample) 2015-07-16
JP6001557B2 JP6001557B2 (ja) 2016-10-05

Family

ID=46147004

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013549652A Active JP6001557B2 (ja) 2011-04-28 2012-04-27 抗ヒト受容体型プロテインチロシンホスファターゼσ抗体
JP2016170634A Active JP6412072B2 (ja) 2011-04-28 2016-09-01 抗ヒト受容体型プロテインチロシンホスファターゼσ抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016170634A Active JP6412072B2 (ja) 2011-04-28 2016-09-01 抗ヒト受容体型プロテインチロシンホスファターゼσ抗体

Country Status (16)

Country Link
US (2) US9803026B2 (enExample)
EP (2) EP2702412B1 (enExample)
JP (2) JP6001557B2 (enExample)
KR (1) KR101873614B1 (enExample)
CN (1) CN103703372B (enExample)
AU (2) AU2012248158C1 (enExample)
CA (1) CA2834243C (enExample)
ES (2) ES2788183T3 (enExample)
HU (2) HUE054211T2 (enExample)
IL (1) IL229127A (enExample)
MX (1) MX352599B (enExample)
PL (2) PL3232202T3 (enExample)
PT (2) PT3232202T (enExample)
RU (2) RU2715642C2 (enExample)
SG (3) SG10202108240VA (enExample)
WO (1) WO2012148003A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20151261T1 (hr) 2007-07-02 2016-01-01 Oncomed Pharmaceuticals, Inc. Sastavi i postupci za lijeäśenje i dijagnosticiranje raka
SG10202108240VA (en) * 2011-04-28 2021-09-29 Sbi Biotech Co Ltd ANTI-HUMAN RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE σ ANTIBODY
JP6185463B2 (ja) 2011-07-15 2017-08-23 オンコメッド ファーマシューティカルズ インコーポレイテッド Rspo結合剤およびその使用法
EA032038B1 (ru) * 2012-07-13 2019-03-29 Онкомед Фармасьютикалс, Инк. Rspo3-связывающие агенты и их применение
EP2877494B1 (en) * 2012-07-23 2020-07-15 La Jolla Institute for Allergy and Immunology Ptprs and proteoglycans in autoimmune disease
US11160873B2 (en) * 2014-02-04 2021-11-02 Monash University Anti-metalloprotease antibody for diagnosis and treatment of cancers
US10023653B2 (en) * 2014-02-04 2018-07-17 Monash University Anti-metalloprotease antibody for diagnosis and treatment of cancers
JP2017528523A (ja) 2014-09-16 2017-09-28 オンコメッド ファーマシューティカルズ インコーポレイテッド 線維性疾患の治療
RU2698205C2 (ru) * 2014-12-18 2019-08-23 Ф. Хоффманн-Ля Рош Аг Способ определения антител, вызывающих комплемент-зависимую цитотоксичность
US11274146B2 (en) * 2017-03-23 2022-03-15 The Trustees Of The University Of Pennsylvania Anti-C5a antibodies and uses thereof
WO2018176019A1 (en) * 2017-03-24 2018-09-27 The Regents Of The University Of California Proteoglycan irregularities in abnormal fibroblasts and therapies based therefrom
US11242398B2 (en) 2017-08-01 2022-02-08 Remd Biotherapeutics, Inc. Anti-OX40 antibodies and methods of activating OX40
EP3826612A4 (en) 2018-07-25 2022-09-14 Accurus Biosciences, Inc. NOVEL CLDN-18.2-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF USE
GB201910899D0 (en) * 2019-07-31 2019-09-11 Scancell Ltd Binding members
CN114867493B (zh) * 2019-10-04 2026-04-10 阿尔伯特爱因斯坦医学院 Kir3dl3是免疫系统的抑制性受体及其用途
WO2023010132A1 (en) 2021-07-30 2023-02-02 The Regents Of The University Of California Ptprs in autoimmunity
CN114426582B (zh) * 2022-01-07 2022-11-25 陕西脉元生物科技有限公司 一种神经特异性烯醇化酶单克隆抗体及其制备方法和应用
CN116041526B (zh) * 2022-11-14 2023-09-29 华中农业大学 一种鼠抗草鱼IgT单克隆抗体及其制备方法和应用
WO2024124164A2 (en) * 2022-12-09 2024-06-13 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of immunostimulatory cytokines to chimeric antigen receptor immune cells
AU2024231685A1 (en) * 2023-03-03 2025-09-25 Case Western Reserve University Cell adhesion molecule targeted immunotherapies
CN118994384B (zh) * 2024-08-09 2025-09-26 陕西脉元生物科技有限公司 抗Ri的人源化单克隆抗体及其应用和基于其的检测方法
CN119874900B (zh) * 2025-03-06 2025-10-17 吉林大学 一种单克隆抗体及其在制备治疗肿瘤药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009656A1 (en) 1993-10-01 1995-04-13 New York University Novel receptor-type phosphotyrosine phosphatase-sigma
AU2003252328A1 (en) 2002-08-01 2004-02-23 Ginkgo Biomedical Research Institute Co., Ltd. Method of detecting mouse interferon-producing cells
KR20050108389A (ko) * 2003-03-14 2005-11-16 다이쇼 세이야꾸 가부시끼가이샤 모노클로날 항체 및 이것을 생산하는 하이브리도마
US8038996B2 (en) 2004-03-27 2011-10-18 University Of Arizona Composition and method for cancer treatment
US20080008719A1 (en) 2004-07-10 2008-01-10 Bowdish Katherine S Methods and compositions for the treatment of prostate cancer
AU2006297173A1 (en) * 2005-09-29 2007-04-12 Viral Logic Systems Technology Corp. Immunomodulatory compositions and uses therefor
WO2009003274A1 (en) 2007-06-29 2009-01-08 The Hospital For Sick Children Susceptibility gene for inflammatory bowel disease
US20110287034A1 (en) * 2008-11-14 2011-11-24 The Brigham And Womens Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
US20120231014A1 (en) * 2009-08-18 2012-09-13 Case Western Reserve University Neural Regeneration
WO2011097327A2 (en) * 2010-02-02 2011-08-11 La Jolla Institute For Allergy & Immunology Compositions and methods of modulating receptor protein tyrosine phosphatases
SG10202108240VA (en) * 2011-04-28 2021-09-29 Sbi Biotech Co Ltd ANTI-HUMAN RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE σ ANTIBODY

Similar Documents

Publication Publication Date Title
CN109563169B (zh) 抗hla-g特异性抗体
CN104507967B (zh) 抗cxcr3抗体
RU2017118262A (ru) АНТИТЕЛО ПРОТИВ ПРОТЕИНТИРОЗИНФОСФАТАЗЫ σ РЕЦЕПТОРНОГО ТИПА ЧЕЛОВЕКА
JP2013538057A5 (enExample)
JP7439076B2 (ja) 抗npr1抗体およびその使用
WO2018137576A1 (zh) 抗pd-1单克隆抗体及其制备方法和应用
JP2014526898A5 (enExample)
AU2015328090A1 (en) Humanized anti-OX40 antibodies and uses thereof
JP2015508056A5 (enExample)
JP2012501670A5 (enExample)
JP2014534806A5 (enExample)
JP2010526028A5 (enExample)
JP2017522903A5 (enExample)
JP2021514973A5 (enExample)
JP2012501669A5 (enExample)
US10556947B2 (en) Binding molecule that binds specifically to the precursor of brain-derived neurotrophic factor
JP2020517241A (ja) Lrig‐1タンパク質に特異的な結合分子およびその用途
JP2017532005A5 (enExample)
KR20140108520A (ko) CD1d에 대한 항체
RU2016107814A (ru) Новое антитело к tslp-рецептору человека
RU2010119450A (ru) Антитело против bst2
JP7618240B2 (ja) 脳神経系疾患の予防または治療用組成物
JP2019520034A5 (enExample)
EP4157867A1 (en) Human recombinant monoclonal antibody against sars-cov-2 spike glycoprotein
EP4199951A2 (en) Cd3/cd25 antibodies for neuro-immune diseases